Montrose Capital Partners logo

Montrose Capital Partners

North America, New York, United States, New York

Description

Montrose Capital is a privately held investment company focused on Public Markets Venture Capital.

Investor Profile

Montrose Capital Partners has made 13 investments, with 0 in the past 12 months and 31% as lead.

Stage Focus

  • Post Ipo Equity (46%)
  • Series Unknown (38%)
  • Pre Seed (8%)
  • Seed (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Manufacturing
  • Pharmaceutical
  • Biopharma
  • Semiconductor
  • Meeting Software
  • Saas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Montrose Capital Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
AngelList
North America, California, United States, San Francisco
Co-Investments: 1
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Xeraya Capital
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 1
Brooklyn Bridge Ventures
North America, New York, United States, New York
Co-Investments: 1
MetaProp
North America, New York, United States, New York
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2
Expansion Venture Capital
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Montrose Capital Partners often collaborate with?

Shared Deals: 1
LB
North America, California, United States, Menlo Park
Shared Deals: 1
JF
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Montrose Capital Partners?

Compass Therapeutics, Inc.

Boston, Massachusetts, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BiopharmaBiotechnologyTherapeutics
Series UnknownJul 1, 2020
Amount Raised: $60,482,210
Odyssey Semiconductor Technologies

Ithaca, New York, United States

Odyssey Semiconductor Technologies is a semiconductor device company developing high-voltage power switching components and systems.

ManufacturingSemiconductor
Series UnknownJul 3, 2019
Amount Raised: $2,502,018
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
Miramar Labs

Sunnyvale, California, United States

Miramar Labs develops medical devices for aesthetic indications that treat primary axillary hyperhidrosis in adults.

Health CareMedicalMedical DevicePharmaceutical
Series UnknownJun 8, 2016
Valeritas

Bridgewater, New Jersey, United States

Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.

BiotechnologyDiabetesHealth CareMedical Device
Series UnknownMay 4, 2016
Bizly

Palo Alto, California, United States

Bizly provides an employee hub for meetings and events.

Meeting SoftwareSaaSSoftware
Pre SeedFeb 1, 2016
Amount Raised: $1,500,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityJul 24, 2015
Amount Raised: $26,700,000
Akoustis

Cornelius, North Carolina, United States

Akoustis™ is a “fabless” high-tech semiconductor company.

Semiconductor
Post Ipo EquityMay 26, 2015
Amount Raised: $5,300,000
Pieris Pharmaceuticals

Boston, Massachusetts, United States

Pieris Pharmaceuticals is a clinical-stage biotechnology company applying its proprietary.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityDec 23, 2014
Amount Raised: $13,600,000
Enumeral Biomedical

New York, New York, United States

Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.

BiotechnologyNanotechnologyPrecision MedicineTherapeutics
Post Ipo EquityAug 4, 2014
Amount Raised: $21,500,000